DHEA, DHEAS and PCOS
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citationMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis
Lin, D., Sugawara, T., Strauss, J. F., Clark, B. J., Stocco, D. M., Saenger, P., Rogol, A., & Miller, W. L. (1995) · Science · doi:10.1126/science.7892608 · Cited by 1,030
NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-83 · Cited by 815
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
Labrie, F., Bélanger, A., Cusan, L., Gomez, J.-L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4160 · Cited by 713 · cited 1×
“003 special character of APAs is the fact that their production is strictly related to age and their levels start decreasing after age 30 [31,32].”
BackgroundYildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I., & Yarali, H. (2012) · Human Reproduction · doi:10.1093/humrep/des232 · Cited by 704
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678 · cited 1×
“Two published GWAS for PCOS have identified 11 susceptibility loci, none of which has a known relationship to APA production [160,161]; to date, the limited studies examining GWAS-derived PCOS genetic variants for association with quantitative traits have not included DHEA or DHEAS [162].”
BackgroundIntraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., & Vinson, G. P. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0326 · Cited by 600 · cited 1×
“However, obesity may also alter adrenal function through the secretion of adipocytokines and other inflammatory products [123], and by increasing the circulating levels of estrogens, through increased aromatization by adipose tissue stromal cells [124–126].”
Background
Research works printed but not linked: 132
- The Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum. Reprod., 19, 41, 10.1093/humrep/deh098 · DOI · Paper page
- NIH Office of Disease Prevention: Evidence-based Methodology Workshop on Polycystic Ovary Syndrome (PCOS), Dec. 3–5, 2012-Final report (http://prevention.nih.gov/p2p/pcos/resources.aspx)
- Knochenhauer, 1998, Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study, J. Clin. Endocrinol. Metab., 83, 3078
- Michelmore, 1999, Polycystic ovaries and associated clinical and biochemical features in young women, Clin. Endocrinol. (Oxf.), 51, 779, 10.1046/j.1365-2265.1999.00886.x · DOI · Paper page
- Diamanti-Kandarakis, 1999, A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile, J. Clin. Endocrinol. Metab., 84, 4006, 10.1210/jcem.84.11.6148 · DOI · Paper page
- Asunción, 2000, A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain, J. Clin. Endocrinol. Metab., 85, 2434
- Azziz, 2004, The prevalence and features of the polycystic ovary syndrome in an unselected population, J. Clin. Endocrinol. Metab., 89, 2745, 10.1210/jc.2003-032046 · DOI · Paper page
- Moran, 2010, Prevalence of polycystic ovary syndrome and related disorders in Mexican women, Gynecol. Obstet. Invest., 69, 274, 10.1159/000277640 · DOI · Paper page
- Mehrabian, 2011, The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria, Endokrynol. Pol., 62, 238
- Boyle, 2012, Prevalence of polycystic ovary syndrome in a sample of indigenous women in Darwin, Australia, Med. J. Aust., 196, 62, 10.5694/mja11.10553 · DOI · Paper page
- Gill, 2012, Prevalence of polycystic ovary syndrome in young women from North India: a community-based study, Indian J. Endocrinol. Metab., 16, S389, 10.4103/2230-8210.104104 · DOI · Paper page
- Li, 2013, Prevalence of polycystic ovary syndrome in women in China: a large community-based study, Hum. Reprod., 28, 2562, 10.1093/humrep/det262 · DOI · Paper page
- Musmar, 2013, Epidemiology of polycystic ovary syndrome a cross sectional study of university students at An-Najah national university-Palestine, Reprod. Biol. Endocrinol., 11, 47, 10.1186/1477-7827-11-47 · DOI · Paper page
- Rashidi, 2014, To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran, Eur. J. Obstet. Gynecol. Reprod. Biology, 174, 100, 10.1016/j.ejogrb.2013.12.018 · DOI
- Labrie, 2005, Is dehydroepiandrosterone a hormone?, J. Endocrinol., 187, 169, 10.1677/joe.1.06264 · DOI · Paper page
- Lin, 1993, Steroid 17α-hydroxylase and 17,20 lyase activities of P450c17: contributions of serine106 and P450 reductase, Endocrinology, 132, 2498, 10.1210/endo.132.6.8504753 · doi:10.1210/endo.132.6.8504753 · Paper page
- Longcope, 1986, Adrenal and gonadal androgen secretion in normal females, Clin. Endocrinol. Metab., 15, 213, 10.1016/S0300-595X(86)80021-4 · DOI · Paper page
- Rijk, 2012, Bovine liver slices: a multifunctional in vitro model to study the prohormone dehydroepiandrosterone (DHEA), Toxicol. In Vitro, 26, 1014, 10.1016/j.tiv.2012.04.012 · DOI
- Labrie, 2007, Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women, J. Steroid Biochem. Mol. Biol., 107, 57, 10.1016/j.jsbmb.2007.02.007 · DOI
- Kumar, 2005, Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS), Clin. Endocrinol. (Oxf.), 62, 644, 10.1111/j.1365-2265.2005.02256.x · DOI · Paper page
- Dharia, 2005, Effects of aging on cytochrome b5 expression in the human adrenal gland, J. Clin. Endocrinol. Metab., 90, 4357, 10.1210/jc.2005-0017 · DOI · Paper page
- Stanczyk, 2006, Diagnosis of hyperandrogenism: biochemical criteria, Best Pract. Res. Clin. Endocrinol. Metab., 20, 177, 10.1016/j.beem.2006.03.007 · DOI
- Carmina, 1992, The ratio of androstenedione-11β-hydroxyandrostenedione is an important marker of adrenal androgen excess in women, Fertil. Steril., 58, 1148, 10.1016/S0015-0282(16)55152-8 · DOI
- Hoffman, 1984, The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women, Fertil. Steril., 42, 76, 10.1016/S0015-0282(16)47961-6 · DOI
- Steinberger, 1984, Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women, J. Clin. Endocrinol. Metab., 59, 471, 10.1210/jcem-59-3-471 · DOI
- Carmina, 1986, Increased DHEAS levels in PCO syndrome: evidence for the existence of two subgroups of patients, J. Endocrinol. Invest., 9, 5, 10.1007/BF03348052 · DOI
- Moran, 1999, Adrenal androgen excess in hyperandrogenism: relation to age and body mass, Fertil. Steril., 71, 671, 10.1016/S0015-0282(98)00536-6 · DOI
- Sánchez, 2002, Adrenal progestogen and androgen production in 21-hydroxylase-deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulation, Fertil. Steril., 77, 750, 10.1016/S0015-0282(01)03236-8 · DOI
- Miller, 1996, Follow-up study of adolescent girls with a history of premature pubarche, J. Adolesc. Health, 18, 301, 10.1016/1054-139X(95)00234-J · DOI
- Ibanez, 1997, Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing, Fertil. Steril., 67, 849, 10.1016/S0015-0282(97)81396-9 · DOI
- Meas, 2002, Endocrine consequences of premature pubarche in post-pubertal Caucasian girls, Clin. Endocrinol. (Oxf.), 57, 101, 10.1046/j.1365-2265.2002.01579.x · DOI · Paper page
- Ibanez, 2000, Premature adrenarche – normal variant or forerunner of adult disease?, Endocr. Rev., 21, 671
- Maliqueo, 2009, Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 94, 3282, 10.1210/jc.2009-0427 · DOI
- Lobo, 1983, Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome, Am. J. Obstet. Gynecol., 145, 496, 10.1016/0002-9378(83)90324-1 · DOI
- Levin, 1991, Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?, Fertil. Steril., 56, 635, 10.1016/S0015-0282(16)54592-0 · DOI
- Carmina, 1994, Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Fertil. Steril., 62, 738, 10.1016/S0015-0282(16)56998-2 · DOI
- Falhammar, 2008, A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation, J. Endocrinol. Invest., 31, 176, 10.1007/BF03345586 · DOI
- Hague, 1990, The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives, Clin. Endocrinol., 33, 501, 10.1111/j.1365-2265.1990.tb03887.x · DOI · Paper page
- Jones, 1953, The use of cortisone in follicular phase disturbances, Fertil. Steril., 4, 49, 10.1016/S0015-0282(16)31144-X · DOI
- Azziz, 1999, Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level, J. Clin. Endocrinol. Metab., 84, 946
- Chang, 1982, Circulating levels of plasma adrenocorticotropin in polycystic ovary disease, J. Clin. Endocrinol. Metab., 54, 1265, 10.1210/jcem-54-6-1265 · DOI
- Horrocks, 1983, ACTH function in women with the polycystic ovarian syndrome, Clin. Endocrinol., 19, 143, 10.1111/j.1365-2265.1983.tb02976.x · DOI
- Mongioi, 1988, Pituitary and adrenal response to ovine corticotropin-releasing hormone in women with polycystic ovarian syndrome, J. Endocrinol. Invest., 11, 637, 10.1007/BF03350202 · doi:10.1007/bf03350202
- Cunningham, 1988, Plasma pro-opiomelanocortin fragments and adrenal steroids following administration of metyrapone to normal and hirsute women, J. Endocrinol. Invest., 11, 247, 10.1007/BF03350147 · doi:10.1007/bf03350147
- Carmina, 1990, Ovine corticotropin-releasing factor and dexamethasone responses in hyperandrogenic women, Fertil. Steril., 54, 245, 10.1016/S0015-0282(16)53697-8 · DOI
- Carmina, 1990, Pituitary adrenal responses to ovine corticotropin releasing hormone in polycystic ovary syndrome and other hyperandrogenic patients, Gynecol. Endocrinol., 4, 225, 10.3109/09513599009024976 · DOI
- Stewart, 1993, The hypothalamo–pituitary–adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome, Clin. Endocrinol. (Oxf.), 38, 387, 10.1111/j.1365-2265.1993.tb00519.x · DOI · Paper page
- Lanzone, 1995, Corticotropin-releasing hormone induces and exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome, Fertil. Steril., 63, 1195, 10.1016/S0015-0282(16)57596-7 · DOI
- Azziz, 1998, Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic–pituitary–adrenal axis, J. Clin. Endocrinol. Metab., 83, 2317
- Gennarelli, 1999, Response of the pituitary–adrenal axis to hypoglycemic stress in women with the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 84, 76, 10.1210/jcem.84.1.5403 · DOI
- Invitti, 1998, Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome, Metabolism, 47, 143, 10.1016/S0026-0495(98)90210-4 · DOI
- Cinar, 2012, Adrenocortical steroid response to ACTH in different phenotypes of non obese polycystic ovary syndrome, J. Ovarian Res., 5, 42, 10.1186/1757-2215-5-42 · DOI
- Glintborg, 2005, Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, Caucasian, hirsute patients compared with healthy controls, J. Clin. Endocrinol. Metab., 90, 1347, 10.1210/jc.2004-1214 · DOI · Paper page
- Lobo, 1981, Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 53, 394, 10.1210/jcem-53-2-394 · DOI · Paper page
- Siegel, 1990, ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism, N. Engl. J. Med., 323, 849, 10.1056/NEJM199009273231301 · DOI · Paper page
- Azziz, 1993, 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism, Am. J. Obstet. Gynecol., 168, 889, 10.1016/S0002-9378(12)90840-6 · DOI
- Moran, 1999, Prevalence of 3beta-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess, Am. J. Obstet. Gynecol., 181, 596, 10.1016/S0002-9378(99)70498-9 · DOI
- Lutfallah, 2002, Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency, J. Clin. Endocrinol. Metab., 87, 2611
- Carbunaru, 2004, The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency, J. Clin. Endocrinol. Metab., 89, 783, 10.1210/jc.2003-030934 · DOI · Paper page
- Moran, 2004, Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess, Fertil. Steril., 81, 126, 10.1016/j.fertnstert.2003.07.008 · DOI
- Rodin, 1994, Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11β-hydroxysteroid dehydrogenase, N. Engl. J. Med., 330, 460, 10.1056/NEJM199402173300703 · DOI · Paper page
- Pasquali, 1998, Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution, Clin. Endocrinol., 48, 603, 10.1046/j.1365-2265.1998.00458.x · DOI · Paper page
- Andrew, 1998, Obesity and gender influence cortisol secretion and metabolism in man, J. Clin. Endocrinol. Metab., 83, 1806, 10.1210/jcem.83.5.4951 · doi:10.1210/jcem.83.5.4951 · Paper page
- Gambineri, 2009, Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome, J. Endocrinol. Invest., 32, 210, 10.1007/BF03346454 · DOI
- Carmina, 2007, Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes, J. Endocrinol. Invest., 30, 111, 10.1007/BF03347408 · DOI
- Azziz, 1991, The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women, J. Clin. Endocrinol. Metab., 72, 1025, 10.1210/jcem-72-5-1025 · DOI
- Hines, 2001, Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies, Fertil. Steril., 76, 730, 10.1016/S0015-0282(01)02014-3 · DOI
- Kumar, 2009, Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line, Fertil. Steril., 92, 793, 10.1016/j.fertnstert.2008.05.076 · DOI
- Azziz, 1998, Role of the ovary in the adrenal androgen excess of hyperandrogenic women, Fertil. Steril., 69, 851, 10.1016/S0015-0282(98)00033-8 · DOI
- Gonzalez, 1991, Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome, Am. J. Obstet. Gynecol., 165, 535, 10.1016/0002-9378(91)90280-5 · DOI
- Carmina, 1995, Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome, Obstet. Gynecol., 6, 26
- Cedars, 1992, Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction, Fertil. Steril., 57, 495, 10.1016/S0015-0282(16)54890-0 · DOI
- Azziz, 2013, Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome, Fertil. Steril., 99, 599, 10.1016/j.fertnstert.2012.10.016 · DOI
- Burghen, 1980, Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease, J. Clin. Endocrinol. Metab., 50, 113, 10.1210/jcem-50-1-113 · DOI · Paper page
- Brennan, 2009, Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome, Fertil. Steril., 91, 1848, 10.1016/j.fertnstert.2008.02.101 · DOI
- Kauffman, 2006, Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome, Fertil. Steril., 85, 1010, 10.1016/j.fertnstert.2005.09.046 · DOI
- Buyalos, 1991, No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease, Fertil. Steril., 56, 1179, 10.1016/S0015-0282(16)54738-4 · DOI
- Buyalos, 1997, Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome, Hum. Reprod., 12, 1138, 10.1093/humrep/12.6.1138 · DOI
- Azziz, 1995, Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1–24) stimulation in hyperandrogenic women, Am. J. Obstet. Gynecol., 172, 1251, 10.1016/0002-9378(95)91488-9 · DOI
- Ludwig, 2009, Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome, Fertil. Steril., 92, 271, 10.1016/j.fertnstert.2008.05.052 · DOI
- Diamond, 1991, Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women, J. Clin. Endocrinol. Metab., 72, 883, 10.1210/jcem-72-4-883 · DOI · Paper page
- Farah-Eways, 2004, Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome, Fertil. Steril., 81, 120, 10.1016/j.fertnstert.2003.05.008 · DOI
- Falcone, 1990, Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women, J. Clin. Endocrinol. Metab., 71, 1653, 10.1210/jcem-71-6-1653 · DOI
- Azziz, 2003, Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome, Fertil. Steril., 79, 932, 10.1016/S0015-0282(02)04914-2 · DOI
- Rautio, 2006, Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study, Hum. Reprod., 21, 1400, 10.1093/humrep/dei505 · DOI · Paper page
- Sepilian, 2005, Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance, J. Clin. Endocrinol. Metab., 90, 60, 10.1210/jc.2004-1376 · DOI · Paper page
- Guido, 2004, Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome, Hum. Reprod., 19, 534, 10.1093/humrep/deh145 · DOI
- Romualdi, 2007, Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome, Fertil. Steril., 88, 131, 10.1016/j.fertnstert.2006.11.076 · DOI
- Aigner, 2009, Retinol-binding protein 4 in polycystic ovary syndrome – association with steroid hormones and response to pioglitazone treatment, J. Clin. Endocrinol. Metab., 94, 1229, 10.1210/jc.2008-2156 · DOI · Paper page
- Glintborg, 2009, A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome, Fertil. Steril., 91, 842, 10.1016/j.fertnstert.2007.12.082 · DOI
- Li, 2011, Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis, Clin. Endocrinol. (Oxf.), 74, 332, 10.1111/j.1365-2265.2010.03917.x · DOI · Paper page
- Majuri, 2007, Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study, Eur. J. Endocrinol., 156, 263, 10.1530/eje.1.02331 · DOI · Paper page
- Sepilian, 2006, Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens, Fertil. Steril., 85, 1441, 10.1016/j.fertnstert.2005.10.038 · DOI
- la Marca, 1999, Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome, Fertil. Steril., 72, 985, 10.1016/S0015-0282(99)00407-0 · DOI
- Forney, 1981, Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia, J. Clin. Endocrinol. Metab., 53, 192, 10.1210/jcem-53-1-192 · DOI · Paper page
- Ackerman, 1981, Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture, J. Clin. Endocrinol. Metab., 53, 412, 10.1210/jcem-53-2-412 · DOI · Paper page
- Azziz, 1991, Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women, Fertil. Steril., 56, 427, 10.1016/S0015-0282(16)54535-X · DOI
- Vicennati, 1998, Secretion of major adrenal androgens following ACTH administration in obese women with different body fat distribution, Hormone Metab. Res., 30, 133, 10.1055/s-2007-978851 · DOI
- Rittmaster, 1993, The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome, J. Clin. Endocrinol. Metab., 76, 1295
- Brody, 1987, Adrenal steroids in post-menopausal women relation to obesity and to bone mineral content, Maturitas, 9, 25, 10.1016/0378-5122(87)90048-X · DOI
- Komindr, 1986, Relative sensitivity and responsivity of serum cortisol and two adrenal androgens to alpha-adrenocorticotropin-(1–24) in normal and obese, nonhirsute, eumenorrheic women, J. Clin. Endocrinol. Metab., 63, 860, 10.1210/jcem-63-4-860 · DOI
- Vicennati, 2000, Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration, J. Clin. Endocrinol. Metab., 85, 4093, 10.1210/jcem.85.11.6946 · doi:10.1210/jcem.85.11.6946 · Paper page
- Rotter, 1985, A genetic component to the variation of dehydroepiandrosterone sulfate, Metabolism, 34, 731, 10.1016/0026-0495(85)90023-X · DOI
- Prom-Wormley, 2011, Genetic and environmental effects on diurnal dehydroepiandrosterone sulfate concentrations in middle-aged men, Psychoneuroendocrinology, 36, 1441, 10.1016/j.psyneuen.2011.03.018 · DOI
- Rice, 1993, The Cincinnati Myocardial Infarction and Hormone Family study: family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families, Metabolism, 42, 1284, 10.1016/0026-0495(93)90126-9 · DOI
- An, 2001, Race differences in the pattern of familial aggregation for dehydroepiandrosterone sulfate and its responsiveness to training in the HERITAGE Family Heart Study, Metabolism, 50, 916, 10.1053/meta.2001.24926 · DOI
- Jaquish, 1996, Quantitative genetics of dehydroepiandrosterone sulfate and its relation to possible cardiovascular disease risk factors in Mexican Americans, Hum. Hered., 46, 301, 10.1159/000154368 · DOI
- Mitchell, 1996, Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study, Circulation, 94, 2159, 10.1161/01.CIR.94.9.2159 · DOI · Paper page
- Jaquish, 1996, Genetic correlations between lipoprotein phenotypes and indicators of sex hormone levels in Mexican Americans, Atherosclerosis, 122, 117, 10.1016/0021-9150(96)05796-6 · DOI
- Li, 2007, Change of dehydroepiandrosterone in serum of 6-18 year-old twin girls in Qingdao city, Wei Sheng Yan Jiu, 36, 41
- Meikle, 1988, Heritability of variation of plasma cortisol levels, Metabolism, 37, 514, 10.1016/0026-0495(88)90164-3 · DOI
- Meikle, 1997, Age genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins, Prostate, 33, 105, 10.1002/(SICI)1097-0045(19971001)33:2<105::AID-PROS4>3.0.CO;2-J · DOI · Paper page
- Nestler, 2002, Genetics of serum dehydroepiandrosterone sulfate and its relationship to insulin in a population-based cohort of twin subjects, J. Clin. Endocrinol. Metab., 87, 682, 10.1210/jcem.87.2.8240 · DOI
- Akamine, 1980, Studies on changes in the concentration of serum adrenal androgens in pubertal twins, Acta Endocrinol. (Copenh.), 93, 356
- Yildiz, 2006, Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters, Fertil. Steril., 86, 1688, 10.1016/j.fertnstert.2006.05.045 · DOI
- Franks, 2008, Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries, J. Clin. Endocrinol. Metab., 93, 3396, 10.1210/jc.2008-0369 · DOI · Paper page
- Goodarzi, 2007, Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters, Am. J. Obstet. Gynecol., 196, e391
- Legro, 2002, Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 2134, 10.1210/jcem.87.5.8387 · doi:10.1210/jcem.87.5.8387 · Paper page
- Goodarzi, 2007, Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 92, 2659, 10.1210/jc.2006-2600 · DOI · Paper page
- Louwers, 2013, Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype, J. Clin. Endocrinol. Metab., 98, 3848, 10.1210/jc.2013-1976 · DOI · Paper page
- Komori, 1990, Fetus-specific expression of a form of cytochrome P-450 in human livers, Biochemistry, 29, 4430, 10.1021/bi00470a024 · DOI · Paper page
- Kuehl, 2001, Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression, Nat. Genet., 27, 383, 10.1038/86882 · DOI · Paper page
- Smit, 2005, A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels, J. Clin. Endocrinol. Metab., 90, 5313, 10.1210/jc.2005-0307 · DOI · Paper page
- Goodarzi, 2008, Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 93, 2909, 10.1210/jc.2008-0403 · DOI
- Escobar-Morreale, 1999, The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype–genotype correlations, Fertil. Steril., 72, 629, 10.1016/S0015-0282(99)00317-9 · DOI
- Witchel, 2005, Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess, Fertil. Steril., 83, 371, 10.1016/j.fertnstert.2004.10.027 · DOI
- Vandenput, 2014, Genome-wide association studies on serum sex steroid levels, Mol. Cell. Endocrinol., 382, 758, 10.1016/j.mce.2013.03.009 · DOI
- Zhai, 2011, Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms, PLoS Genet., 7, e1002025, 10.1371/journal.pgen.1002025 · DOI · Paper page
- Cui, 2013, Genotype–phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women, Hum. Reprod., 28, 538, 10.1093/humrep/des424 · DOI · Paper page
- Khaw, 1996, Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease, J. Endocrinol., 150, S149
- Ohlsson, 2010, Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men, J. Clin. Endocrinol. Metab., 95, 4406, 10.1210/jc.2010-0760 · DOI
- Shufelt, 2010, DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health? National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women’s Ischemia Syndrome Evaluation (WISE), J. Clin. Endocrinol. Metab., 95, 4985, 10.1210/jc.2010-0143 · DOI · Paper page
Cited by
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationRosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
The Regulation of Steroid Action by Sulfation and Desulfation
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419
Calcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
Metadata
- Authors
- Goodarzi, M. O., Carmina, E., & Azziz, R.
- Venue
- The Journal of Steroid Biochemistry and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 145
- Pages
- 213-225
- ISSN
- 0960-0760 (ISSN-L)
- OpenAlex
- W2011497283
- Cited by
- 188
- References
- 31
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DHEA, DHEAS and PCOS. https://app.cochat.ai/papers/10.1016/j.jsbmb.2014.06.003
- The paper
- Goodarzi, M. O., Carmina, E., & Azziz, R. (2015). DHEA, DHEAS and PCOS. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2014.06.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.